相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Race/Ethnic Difference in Diabetes and Diabetic Complications
Elias K. Spanakis et al.
CURRENT DIABETES REPORTS (2013)
What are the preferred strategies for control of glycaemic variability in patients with type 2 diabetes mellitus?
L. Zenari et al.
DIABETES OBESITY & METABOLISM (2013)
The Effect of Pioglitazone and Metformin on Liver Function Tests, Insulin Resistance, and Liver Fat Content in Nonalcoholic Fatty Liver Disease: A Randomized Double Blinded Clinical Trial
Mohsen Razavizade et al.
HEPATITIS MONTHLY (2013)
Glycemic Effectiveness of Metformin-Based Dual-Combination Therapies with Sulphonylurea, Pioglitazone, or DPP4-Inhibitor in Drug-Naive Korean Type 2 Diabetic Patients
Young Ki Lee et al.
DIABETES & METABOLISM JOURNAL (2013)
Effect of addition of either sitagliptin or pioglitazone in patients with uncontrolled type 2 diabetes mellitus on metformin: A randomized controlled trial
Shalini Chawla et al.
JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS (2013)
Effects of Pioglitazone Add-On to Gliclazide and Metformin on Glycemic Control in Patients with Type 2 Diabetes
Sayer I. Al-Azzam et al.
ENDOCRINE RESEARCH (2012)
Health Disparities in Endocrine Disorders: Biological, Clinical, and Nonclinical Factors-An Endocrine Society Scientific Statement
Sherita Hill Golden et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
PIOfix-Study: Effects of Pioglitazone/Metformin Fixed Combination in Comparison with a Combination of Metformin with Glimepiride on Diabetic Dyslipidemia
Andreas Pfuetzner et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2011)
The Effects of Pioglitazone in Reducing Atherosclerosis Progression and Neointima Volume in Type 2 Diabetic Patients: Prospective Randomized Study With Volumetric Intravascular Ultrasonography Analysis
Sung Hye You et al.
Korean Circulation Journal (2011)
Efficacy and Tolerability of Pioglitazone in Patients with Type 2 Diabetes Mellitus Comparison with Other Oral Antihyperglycaemic Agents
Giuseppe Derosa
DRUGS (2010)
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis.
Arun J. Sanyal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Depressive symptoms and diabetes mellitus in an Asian multiracial population
Siow Ann Chong et al.
ASIAN JOURNAL OF PSYCHIATRY (2009)
PPAR agonists: multimodal drugs for the treatment of type-2 diabetes
Barbara Gross et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis
Renata Belfort et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Comparison of effect of pioglitazone with metformin or sulfonylurea (monotherapy and combination therapy) on postload glycemia and composite insulin sensitivity index during an oral glucose tolerance test in patients with type 2 diabetes
A Ceriello et al.
DIABETES CARE (2005)
Drug therapy: Thiazolidinediones
H Yki-Jarvinen
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Molecular mediators of hepatic steatosis and liver injury
JD Browning et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Decreased plasma adiponectin concentrations are closely related to hepatic fat content and hepatic insulin resistance in pioglitazone-treated type 2 diabetic patients
M Bajaj et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Lipids and lipoproteins in patients with type 2 diabetes
RM Krauss
DIABETES CARE (2004)
Effect of thiazolidinediones on body weight in patients with diabetes mellitus
V Fonseca
AMERICAN JOURNAL OF MEDICINE (2003)
Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference
BA Neuschwander-Tetri et al.
HEPATOLOGY (2003)
Effect of pioglitazone compared with metformin on glycemic control and indicators of insulin sensitivity in recently diagnosed patients with type 2 diabetes
I Pavo et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
分享论文
